Tilray Inc. ($TLRY) Stock Forecast: Down 5.1% Today

What is Tilray Inc.?

A cannabis producer, Tilray Brands Inc. (TLRY), has expanded its business by acquiring craft beer brands in an effort to reduce its dependence on the cannabis sector. The company's stock has displayed notable volatility with significant fluctuations recently.

Why is Tilray Inc. going down?

TLRY stock is down 5.1% on Apr 7, 2026 15:40

• Despite a positive day in the broader market, Tilray's stock faced a downward trend, closing at $6.66.
• Analysts hold differing views on Tilray, resulting in a consensus "Hold" rating and an average price target of $11.20. This reflects uncertainty regarding the company's future profitability.
• Investors have expressed concerns about Tilray's persistent operational losses, narrow margins, and high expenses, leading to a substantial 97% decline in the stock value over the past five years.
• The recent uptick in Tilray's stock price is possibly linked to short-term positive momentum driven by operational advancements in Q3. However, technical analysis indicates a consolidation range between $6.50 and $7.00, with potential downside risks due to the absence of strong buy signals.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Tilray Brands (NASDAQ:TLRY) Stock Price Up 1.7% - Time to Buy?

Tilray Brands (NASDAQ:TLRY) saw its stock price rise 1.7% to $6.66, although trading volume was slightly below average. Analysts have a mixed outlook, with a consensus "Hold" rating and an average price target of $11.20, despite a recent earnings miss on EPS. The company remains unprofitable with negative margins, and institutional investors have recently adjusted their holdings.

https://www.marketbeat.com/instant-alerts/tilray-brands-nasdaqtlry-stock-price-up-17-time-to-buy-2026-04-06/

Tilray Brands Inc. stock rises Monday, outperforms market

Tilray Brands Inc. (TLRY) shares increased by 1.68% on Monday, closing at $6.66. This rise occurred during a positive trading session for the broader market, with both the NASDAQ Composite Index and the Dow Jones Industrial Average also seeing gains. This marks the second day of consecutive gains for Tilray's stock.

https://www.marketwatch.com/data-news/tilray-brands-inc-stock-rises-monday-outperforms-market-09189584-c3b7cdfad01f?gaa_at=eafs&gaa_n=AWEtsqeNOMqvt6fGZocYAlr2S3jADOuEht6ECxHyYCmRR01_0GAKtWpSxMAs&gaa_ts=69d4aa87&gaa_sig=hLgRVwndCReTVKc0RWD617z0ai4WGqeSf2q4sO7mwinhjCRj0flctoNXnuryqc13yGsAePrvT57nri7dijU7Ag%3D%3D

Why Tilray Brands Investors Shouldn't Expect the Company to Post a Profit Anytime Soon

Tilray Brands, a cannabis producer, has been diversifying its business by acquiring craft beer brands to reduce its reliance on the cannabis industry. While this strategy has increased its top line, the company continues to incur operating losses due to thin margins, high costs, and ongoing expansion efforts. Investors are cautioned against expecting profitability soon, as the stock has lost 97% of its value in five years, making it a speculative investment.

https://www.fool.com/investing/2026/04/06/why-tilray-brands-investors-shouldnt-expect-the-co/

Tilray stock price forecast: $6.50–$7.00 range as TLRY rises 4.50%

Tilray Brands Inc. (TLRY) saw a 4.50% rise, trading at $6.85, positioned above its MA-20 but below its MA-50 and MA-200, indicating short-term bullish momentum within a longer-term negative trend. The company reported 11% organic revenue growth in Q3, driven by beverage expansion and medical cannabis initiatives, and reduced its net loss. Despite these operational improvements, technical indicators suggest the stock is likely to consolidate between $6.50 and $7.00, with downside risk persisting due to a lack of strong buy signals.

https://tradersunion.com/news/financial-news/show/1846938-tilray-up-4-50percent-today-at/

Tilray Brands, Inc. (NASDAQ:TLRY) Receives Consensus Recommendation of "Hold" from Brokerages

Tilray Brands, Inc. (NASDAQ:TLRY) has received a consensus "Hold" recommendation from nine brokerages, with an average 12-month price objective of $11.20. Despite revenue beating estimates in Q3 2026, the company reported an EPS miss and remains unprofitable. Analyst opinions are mixed, with some upgrading the stock due to positive sentiment and potential regulatory tailwinds, while others express caution regarding margins and execution risks.

https://www.marketbeat.com/instant-alerts/tilray-brands-inc-nasdaqtlry-receives-consensus-recommendation-of-hold-from-brokerages-2026-04-05/

Trending Today

Patterson-UTI Energy Inc. ($PTEN) Stock Forecast: Up 5.1% Today

Palo Alto Networks Inc. ($PANW) Stock Forecast: Up 4.7% Today

Crowdstrike Holdings Inc. ($CRWD) Stock Forecast: Up 5.1% Today

Atlassian Corporation Plc ($TEAM) Stock Forecast: Down 5.1% Today

The Trade Desk Inc ($TTD) Stock Forecast: Down 6.3% Today

Rocket Companies Inc ($RKT) Stock Forecast: Down 5.0% Today

Broadcom Inc. ($AVGO) Stock Forecast: Up 5.9% Today

Gartner Inc. ($IT) Stock Forecast: Down 5.1% Today

Enphase Energy Inc. ($ENPH) Stock Forecast: Down 5.4% Today

Humana Inc. ($HUM) Stock Forecast: Up 8.8% Today

Tilray Inc. Price History

02.03.2026 - TLRY Stock was up 6.5%

• Strong Q3 earnings and a surge in international cannabis revenue contributed to Tilray exceeding revenue expectations, prompting a positive market response.
• Analysts raised their rating on Tilray to Buy, setting a price target of $10, and expressed optimism about the company's future growth potential.
• Despite the favorable earnings, concerns over varying margin trends, uncertainty in EPS reporting, and analyst downgrades caused a brief 5.1% decrease in the stock price after the earnings release, revealing the difficulties in maintaining consistent profitability amid revenue growth.

02.03.2026 - TLRY Stock was up 5.4%

• Despite achieving record Q3 revenue of $206.7 million, Tilray's stock declined by 5.1% due to concerns about mixed margin trends, confusion around EPS reporting, and analyst downgrades.
• The company's efforts in international cannabis revenue growth and strategic acquisitions were somewhat overshadowed by difficulties in converting top-line growth into consistent profit enhancements.
• Investors have reservations concerning a notable adjusted EPS shortfall, ongoing shareholder dilution, and slow advancements in U.S. cannabis rescheduling, which have influenced market perceptions despite the positive revenue outcome.
• Tilray's stock performance fell short of market expectations, closing well below its 52-week high, reflecting investor sentiment towards the company's financial performance and growth strategies.

10.02.2026 - TLRY Stock was up 6.9%

• TLRY's bullish movement can be attributed to its strategic acquisition of BrewDog's Australian assets, including the Brisbane brewery and a network of bars, to expand its presence in the Asia-Pacific region.
• The expansion into Australia serves as a gateway for Tilray to introduce its broader beverage portfolio to new markets, enhancing its global beverage revenues.
• This move not only strengthens Tilray's international brewing footprint but also positions the company to capitalize on the growing demand for craft beverages in the Asia-Pacific market, driving investor optimism and contributing to the bullish market movement of TLRY.

01.03.2026 - TLRY Stock was down 5.1%

• Despite reporting record Q3 revenue of $206.7 million, Tilray's stock experienced a bearish movement due to concerns over a significant adjusted EPS miss, continuous shareholder dilution, and slow progress in U.S. cannabis rescheduling.
• The surge in international cannabis sales by 73% sparked a rally in Tilray's shares, but the narrowed net loss that still missed consensus might have contributed to the overall bearish sentiment.
• Anticipation of strong Q3 earnings, a new product launch, and decreased short interest led to a premarket surge in Tilray's stock, indicating short-term gains amidst a longer-term downtrend.
• Investors are eagerly waiting for revenue growth to translate into sustainable profitability for Tilray, as the company navigates through challenges and opportunities in the cannabis market.

20.02.2026 - TLRY Stock was down 5.4%

• Acquired BrewDog's US assets to expand alcohol beverage portfolio did not have a positive impact on stock price.
• Despite expanding medical cannabis portfolio in Australia, introducing new products did not prevent bearish trend.
• Underperformance compared to broader market and sector, along with anticipation of negative earnings per share in upcoming report, likely led to bearish movement.
• Consecutive days of losses amidst challenging trading session for overall market emphasized bearish sentiment surrounding the stock.

30.02.2026 - TLRY Stock was down 5.2%

• Despite beating quarterly EPS and revenue estimates, Tilray's stock saw a significant dip, possibly due to concerns about the company's profitability and negative EPS forecasts for the current year.
• The lawsuit filed by Bob Marley's heirs against Tilray for unpaid licensing fees may have added to investor uncertainty and contributed to the bearish movement of the stock.
• The partnership announcement with Popsicle to launch new alcoholic beverages could have been overshadowed by the negative market sentiment, failing to provide a positive impact on the stock price.
• Analysts' adjustments to price targets and earnings estimates, along with the overall market downturn, likely influenced investors to sell off Tilray shares, leading to the underperformance of the stock.

26.02.2026 - TLRY Stock was down 5.2%

• Concerns arose among investors due to Tilray's partnership with Popsicle to launch "Popsicle Hard" beverages, potentially affecting its core business focus.
• The anticipation of Tilray's third-quarter fiscal year 2026 financial results on April 1, 2026, could be causing uncertainty and volatility in the stock.
• Investor caution regarding the financial results may lead to a sell-off of Tilray stock in expectation of disappointing earnings or guidance.
• The absence of specific positive updates or catalysts may be contributing to the bearish sentiment surrounding Tilray's stock today.

25.02.2026 - TLRY Stock was up 6.6%

• The increase in Tilray's stock price is likely the result of oversold conditions, leading to short-term optimism among investors.
• Anticipation for the upcoming third fiscal quarter results scheduled for April 1, 2026, has contributed to positive market sentiment.
• Despite facing profitability challenges with a negative net margin, recent company activities such as acquiring BrewDog U.S. assets and expanding medical cannabis partnerships have bolstered investor confidence.
• Analyst opinions on the stock vary, with a consensus "Hold" rating; however, the temporary rebound suggests that investors are cautiously positive about Tilray's future prospects.

25.02.2026 - TLRY Stock was up 8.2%

• TLRY stock rose by 3.57% to $6.68 today, following recent bearish trends, despite trading below significant moving averages.
• The stock's uptick may be linked to oversold conditions identified by certain technical indicators, attracting short-term investors seeking opportunities.
• Uncertainty over U.S. federal cannabis rescheduling discussions continues to impact investor sentiment, contributing to the stock's volatility.
• TLRY's recent acquisition of craft brewer BrewDog and CEO Irwin Simon's plans to revitalize the brand through expansion efforts may have also influenced the positive market movement, highlighting the company's commitment to diversification and growth strategies.

07.03.2026 - TLRY Stock was down 5.1%

• Despite a positive day in the broader market, Tilray's stock faced a downward trend, closing at $6.66.
• Analysts hold differing views on Tilray, resulting in a consensus "Hold" rating and an average price target of $11.20. This reflects uncertainty regarding the company's future profitability.
• Investors have expressed concerns about Tilray's persistent operational losses, narrow margins, and high expenses, leading to a substantial 97% decline in the stock value over the past five years.
• The recent uptick in Tilray's stock price is possibly linked to short-term positive momentum driven by operational advancements in Q3. However, technical analysis indicates a consolidation range between $6.50 and $7.00, with potential downside risks due to the absence of strong buy signals.

27.02.2026 - TLRY Stock was down 5.0%

• Concerns arose among investors over Tilray's decision to enter the alcoholic ready-to-drink beverages market through a licensing agreement with The Magnum Ice Cream Company.
• The upcoming quarterly earnings report, along with predictions of a potential EPS loss despite revenue growth from new beverage products, contributed to the negative market sentiment.
• The general market downturn, as evidenced by declines in the NASDAQ Composite Index and the Dow Jones Industrial Average, influenced the selling pressure on Tilray stock.
• Despite recent positive developments such as new partnerships and product launches, Tilray's stock struggled to surpass key moving averages, and conflicting analyst opinions may have fueled the downward trajectory.

31.02.2026 - TLRY Stock was up 5.3%

• The launch of Shock Top's "High Voltage" beer with bold orange flavors and a 9.6% ABV has created market buzz. However, investor focus appears to be more on the company's financial standing.
• Despite Tilray surpassing quarterly estimates, analysts have downgraded the stock to a "Hold" and reduced price targets, indicating concerns about profitability and financial well-being.
• The forthcoming earnings report on April 1st will be a key factor in shaping the stock's future direction, with investors eager to see if Tilray's financial performance shows any signs of recovery.
• Despite prevailing pessimism, the rise in institutional investors' holdings in the cannabis firm suggests enduring confidence in Tilray's growth prospects, potentially offering some stability to the stock in the short term.